Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TVGN

Tevogen Bio (TVGN)

Tevogen Bio Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TVGN
DateTimeSourceHeadlineSymbolCompany
05/16/20241:00PMGlobeNewswire Inc.Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic InitiativesNASDAQ:TVGNTevogen Bio Holdings Inc
05/10/20244:40PMGlobeNewswire Inc.Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational ObjectivesNASDAQ:TVGNTevogen Bio Holdings Inc
05/01/20247:05AMGlobeNewswire Inc.Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational ObjectivesNASDAQ:TVGNTevogen Bio Holdings Inc
04/26/20248:23AMGlobeNewswire Inc.Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership AppointmentsNASDAQ:TVGNTevogen Bio Holdings Inc
04/11/20247:05AMGlobeNewswire Inc.Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target CancersNASDAQ:TVGNTevogen Bio Holdings Inc
04/03/20247:05AMGlobeNewswire Inc.Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate DevelopmentNASDAQ:TVGNTevogen Bio Holdings Inc
03/28/20247:05AMGlobeNewswire Inc.Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion PriceNASDAQ:TVGNTevogen Bio Holdings Inc
03/20/20246:00AMBusiness WireTevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 VariantNASDAQ:TVGNTevogen Bio Holdings Inc
03/05/20247:00AMBusiness WireTevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at VeritaNASDAQ:TVGNTevogen Bio Holdings Inc
03/04/20243:24PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TVGNTevogen Bio Holdings Inc
02/27/20243:39PMBusiness WireMittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AINASDAQ:TVGNTevogen Bio Holdings Inc
02/22/20247:13PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TVGNTevogen Bio Holdings Inc
02/22/20247:09PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TVGNTevogen Bio Holdings Inc
02/21/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TVGNTevogen Bio Holdings Inc
02/21/20246:00AMBusiness WireCell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID TreatmentNASDAQ:TVGNTevogen Bio Holdings Inc
02/20/20247:57AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TVGNTevogen Bio Holdings Inc
02/16/202411:17PMBusiness WireCell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open MarketNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:20PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:19PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:17PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:15PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
02/16/20244:14PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:TVGN